Influx Healthtech Ltd. was incorporated on September 28, 2020. The company is a healthcare-focused Contract Development and Manufacturing Organisation (CDMO). It offers specialised manufacturing services across sectors, including dietary supplements, cosmetics, ayurvedic products, veterinary feed, homecare items, APIs, and finished dosage forms like tablets, capsules, and injectables
| Bidding Dates |
|---|
| 18 Jun 2025 - 20 Jun 2025 |
| Subscription |
|---|
| 187.32x Oversubscribed |
| Minimum Investment | Minimum Lot | Maximum Lot | Lot Size | Number of Shares | Issue Price Band | Post Issue Promoter Holding % | Issue Size | IPO Document |
|---|---|---|---|---|---|---|---|---|
| ₹1,09,200 | 1 | 1 | 1200 | 6.1 M | ₹91 - ₹96 | 73.53 % | ₹555.2 M - ₹585.7 M | RHP DOC |
Influx Healthtech IPO SUBSCRIPTION STATUS
20 Jun '25Influx Healthtech IPO overall subscription rate was 187.32 times the total available shares
Influx Healthtech IPO retail subscription rate was 156.36 times in the retail segment
Influx Healthtech IPO non-institutional investor subscription rate was 639.84 times in the non-institutional investor category
Influx Healthtech IPO Qualified Institutional Bidder subscription rate was 73.24 times the available shares for Qualified Institutional Bidder
| Day | Retail Individual Investor | HNI (NII) Investors | Qualified Institutional Buyers |
|---|---|---|---|
| Category Reservation | 35% | 15% | 50% |
20 Jun 2025 (Day 3) | 156.36x | 639.84x | 73.24x |
19 Jun 2025 (Day 2) | 47.46x | 43.29x | 0.9x |
18 Jun 2025 (Day 1) | 10.98x | 7.67x | 0.78x |
Influx Healthtech FINANCIALS
| Period | Net Profit (Rs in crore) | Revenue from Operations (Rs in crore) | Cash Flow from Operations (Rs in crore) | Free Cash Flow (Rs in crore) | Margins |
| FY25 | 13.4 | 104.9 | 7.1 | -1.2 | 19.6% |
| FY24 | 11.1 | 100.0 | 8.9 | 0.6 | 17.0% |
| FY23 | 7.2 | 76.1 | 6.8 | 1.9 | 14.1% |
Influx Healthtech IPO SUBSCRIPTION STATUS DETAILS
Influx Healthtech had 6.1 M shares on offer
Influx Healthtech IPO offer price was in the range ₹91 - ₹96
Influx Healthtech IPO minimum Investment was ₹109200
Influx Healthtech IPO issue size was ₹ 555.2 M - ₹ 585.7 M
Influx Healthtech had a minimum lot size of 1200 Shares per application
Influx Healthtech NUMBER OF SHARES ON OFFER
Influx Healthtech IPO IMPORTANT DATES
| Issue Open Date | 18 Jun 2025 |
| Issue close Date | 20 Jun 2025 |
| Allotment Date | 23 Jun 2025 |
| Refund Date | 24 Jun 2025 |
| Demat Account Credit Date | 24 Jun 2025 |
| Listing Date | 25 Jun 2025 |
| Listing on Exchange(s) | NSE |
| Influx Healthtech Allotment Status | Exchange/ Registrar |
Influx Healthtech IPO subscription opened on 18 Jun 2025, and closed on 20 Jun 2025
IPO allotment for Influx Healthtech was finalized on Monday, 23 Jun 2025
IPO listing for Influx Healthtech was on NSE on Wednesday, 25 Jun 2025
Influx Healthtech IPO LISTING GAINS
| Issue Price (adjusted) | 96.0 |
| Listing Open Price | 132.5 |
| Listing Close Price | 126.2 |
| Listing Gain% | 38.0% |
| Current Gain% | 195.4% |
Influx Healthtech Peer
| Stock | Stock Price | Market Cap (Rs crore) | PE TTM | PEG TTM | PS TTM | ROE% | ROA% | Annual Revenue (Rs crore) | Annual Revenue Growth % | Annual Net Profit (Rs crore) | Annual Net Profit Growth % | EPS TTM | EPS TTM Growth % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Influx Healthtech Ltd. | 283.6 | 656.5 | 32 | 4.4 | 20.4 | 16.6 | 148.2 | 20.5 | 8.9 | ||||
| Sun Pharmaceutical Industries Ltd. | 1945 | 466670.7 | 38.6 | 2.3 | 7.8 | 13.7 | 10.6 | 60433.8 | 10.8 | 11479.4 | 5 | 50.4 | 16.6 |
| Divi's Laboratories Ltd. | 8275 | 219675.3 | 75.1 | 2.8 | 19.6 | 15.3 | 12.8 | 11067 | 14 | 2568 | 17.2 | 110.2 | 26.8 |
| Torrent Pharmaceuticals Ltd. | 4924 | 187293.2 | 85.9 | 9.6 | 11.9 | 25.8 | 4.9 | 13886.2 | 20.3 | 2163.4 | 13.2 | 57.3 | 8.9 |
| Cipla Ltd. | 1463.8 | 118253.6 | 35.1 | -0.9 | 4.2 | 11.3 | 9.1 | 29044.6 | 2.2 | 3879.2 | -26.4 | 41.7 | -37.5 |
| Zydus Lifesciences Ltd. | 1114.2 | 112114.6 | 22.2 | 2.3 | 4.1 | 18.6 | 9.6 | 27657.9 | 17.6 | 5040 | 11.4 | 50.1 | 9.6 |
Influx Healthtech INFORMATION ON IPO ISSUE
About Influx Healthtech
Influx Healthtech Ltd. was incorporated on September 28, 2020. The company is a healthcare-focused Contract Development and Manufacturing Organisation (CDMO). It offers specialised manufacturing services across sectors, including dietary supplements, cosmetics, ayurvedic products, veterinary feed, homecare items, APIs, and finished dosage forms like tablets, capsules, and injectables
Object of the Issue
- Funding capital expenditure requirements to set up a manufacturing facility for the Nutraceutical Division
- Funding capital expenditure requirements to set up a manufacturing facility for the Veterinary Food Division
- Purchase of machinery for Homecare & Cosmetic Division
- General corporate purposes
Influx Healthtech - PROMOTERS
| Name |
|---|
| Munir Abdul Ganee Chandniwala |
| Shirin Munir Ahmed Chandniwala |
| Abdul Ganee Abdul Rasul Chandniwala |
Influx Healthtech Book Running Lead Manager
Rarever Financial Advisors Private Limited
ipo.influxhealth@rarever.in
Influx Healthtech Registrar to the issue
Maashitla Securities Private Limited
investor.ipo@maashitla.com
Influx Healthtech Strengths
Diversified product portfolio
The company specialises in contract manufacturing a diverse range of products, including multi-nutritional tablets, dietary supplements, Ayurvedic products, oral dispersible films, gummies, and ice sticks. Its broad portfolio reflects its adaptability, innovation, and commitment to meeting varied customer needs across market segments
Quality assurance & control
The company maintains strict quality control at every stage of manufacturing to ensure its products meet customer requirements and pass all validations. This commitment to quality ensures consistent excellence across its offerings
Formulation development
The company’s Formulation Development Department drives innovation by creating market-ready solutions for third-party clients, ensuring products meet both consumer needs and regulatory standards
Influx Healthtech Risks
Cost overruns
The company has yet to place orders for machinery/equipment for its proposed expansion. Any delays or vendor issues may lead to time and cost overruns
Price fluctuation risks
The company depends on third-party suppliers for raw materials, mostly sourced from the spot market without long-term contracts, exposing it to price volatility and supply risks. Inability to pass on cost increases or secure timely, quality supplies may impact margins, cause production delays, and affect revenue and customer retention
Counterfiet risks
The company faces the risk of counterfeit or look-alike products being sold under its brand by entities in India and abroad. Such imitation can harm its goodwill and reduce market share by diverting demand away from genuine products
IPO FAQs
This IPO consists of an offer for sale of up to Rs 10.6 crore, of 1,100,400 shares. It also consists of a fresh issue of Rs 48.0 crore.
The promoters of the company are Munir Abdul Ganee Chandniwala, Shirin Munir Ahmed Chandniwala and Abdul Ganee Abdul Rasul Chandniwala.
The category allocation of qualified institutional buyers is 50.0%, the category allocation of non individual investors or high networth individuals is 15.0% and for retail investors it is 35.0%.
The price band of the IPO is Rs 91.0 - 96.0.
The IPO application opens on Jun 18, 2025 and closes on Jun 20, 2025.
The minimum lot size for the IPO is 1200. The maximum lot size for the IPO is 1200.
For all category investors, the minimum application amount for this IPO is Rs. 109,200.0, the maximum value for this IPO is Rs 115,200.0.
This IPO will be allotted on Jun 23, 2025.
The refund will be credited to your account on Jun 24, 2025.
The allotted shares will be credited to your demat on Jun 24, 2025.
Influx Healthtech Ltd.’s shares listed on the stock exchanges on Jun 25, 2025.